1The ALLHAT Officers and coordinators for the ALLHAT collaboratine Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.The antihypertensive and lipid-lowering trertment to prevent heart attack trial (ALLHAT)[J]. JAMA,2002,288:2981-2997.
2Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antiby pertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish trial in old patients with hypertension-2study[J]. Lancet, 1999,354:1751- 1756.
3Hansson L, Zanchetti A. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension on Optimal Treatment (HOT) randomised trial[J].Lancet,1998,351:1755-1762.
4UK Prospective Diabetes Study Group. Tight blood pressure control and risk of maerovascular and microvascular complications in type 2 diabetes:UKPDS.38[J].BMJ, 1998,317:703-713.
5Morris J B, Christopher R palmer, et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calciumchannel blocker or diuretic in the International Nifedipine GTTS study:intervention as a Goal in Hypertension Treatment (Insight)[J].Lancet,2000,356:366-372.
